Leaflet ROBINUL 0.2mg / ml solution for injection

Product code:
W69323001
Quantity:
10
Indicated for:
chronic obstructive pulmonary disease
Route of administration:
injectable
Substance:
glycopyrronium bromide (bronchodilator)
ATC
A03AB02 — Alimentary tract and metabolism | Drugs for functional gastrointestinal disorders | Drugs for functional gastrointestinal disorders | Synthetic anticholinergics, quaternary ammonium compounds

Precautions:

Glaucoma warning

Use caution if you have glaucoma or increased eye pressure.

Anticholinergic effects

May cause dry mouth, constipation, urinary retention, or blurred vision.

Elderly warning

Older people may have an increased risk of side effects.

Glycopyrronium bromide is an anticholinergic medication primarily used for the treatment of obstructive respiratory diseases, such as chronic obstructive pulmonary disease (COPD). It works by blocking muscarinic receptors in the airways, leading to relaxation of bronchial smooth muscles and airway dilation, making breathing easier.

It is indicated for:

- Maintenance treatment of COPD to relieve symptoms such as shortness of breath.
- Reducing the frequency of disease exacerbations.

Glycopyrronium bromide is administered via an inhaler, usually once daily, as directed by a doctor.

Side effects may include dry mouth, throat irritation, cough, constipation, headache, or, rarely, allergic reactions. It is contraindicated in patients with hypersensitivity to glycopyrronium or other anticholinergics and should be used with caution in those with narrow-angle glaucoma, urinary retention, or other conditions that may be worsened by anticholinergic effects.

General data about ROBINUL 0.2mg / ml

Substance:
glycopyrronium bromide
Date of latest medicines list:
01-01-2026
Product code:
W69323001
Concentration:
0.2mg / ml
Pharmaceutical form:
solution for injection
Quantity:
10
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
KERN PHARMA, S.L. - SPANIA
Holder:
CN UNIFARM S.A. - ROMANIA
Number:
768/2022/01
Shelf life:
3 years

Pharmaceutical forms available for glycopyrronium bromide

Concentrations available for glycopyrronium bromide

  • 0.2mg/ml
  • 2.2mg/dose
  • 320mcg/ml
  • 44mcg